13,236 Shares in Astera Labs, Inc. $ALAB Acquired by VectorGlobal IAG Inc.

VectorGlobal IAG Inc. bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 13,236 shares of the company’s stock, valued at approximately $1,451,000.

Several other institutional investors also recently bought and sold shares of ALAB. Reflection Asset Management purchased a new stake in shares of Astera Labs during the 4th quarter valued at $25,000. Smartleaf Asset Management LLC boosted its position in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in Astera Labs during the 4th quarter worth $33,000. Whipplewood Advisors LLC grew its stake in Astera Labs by 15,950.0% during the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after buying an additional 319 shares during the last quarter. Finally, Assetmark Inc. increased its position in Astera Labs by 78.9% during the 4th quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after buying an additional 101 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have commented on ALAB. JPMorgan Chase & Co. increased their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. TD Cowen boosted their price target on Astera Labs from $225.00 to $425.00 and gave the stock a “hold” rating in a research note on Monday, July 13th. Needham & Company LLC upped their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Rothschild & Co Redburn started coverage on shares of Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. Finally, Morgan Stanley lifted their target price on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Thirteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $284.25.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $311.23 on Monday. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The stock has a market cap of $53.35 billion, a price-to-earnings ratio of 210.29, a PEG ratio of 3.61 and a beta of 3.84. The business has a 50-day moving average price of $359.97 and a 200-day moving average price of $230.19.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the prior year, the firm earned $0.33 earnings per share. Astera Labs’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts anticipate that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the completion of the transaction, the director owned 57,466 shares of the company’s stock, valued at $25,859,700. This trade represents a 5.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of the business’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the transaction, the director owned 286,863 shares of the company’s stock, valued at $131,492,261.94. This represents a 2.87% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 1,676,845 shares of company stock worth $444,928,806. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.